113 related articles for article (PubMed ID: 12395886)
1. Relationship between response to interferon-alpha and function of peripheral blood mononuclear cells in chronic hepatitis C patients.
Esquivel F; Albillos A; Carrión F; Prieto A; Reyes E; Martínez-Martin B; Calleja JL; Cacho G; Alvarez-Mon M
Dig Dis Sci; 2002 Oct; 47(10):2154-62. PubMed ID: 12395886
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis C virus-specific T-cell reactivity during interferon and ribavirin treatment in chronic hepatitis C.
Cramp ME; Rossol S; Chokshi S; Carucci P; Williams R; Naoumov NV
Gastroenterology; 2000 Feb; 118(2):346-55. PubMed ID: 10648463
[TBL] [Abstract][Full Text] [Related]
3. Rapid virological response in peripheral blood mononuclear cells with an increase of hepatitis C virus-specific interferon-gamma production predisposes to sustained virological response in patients with chronic hepatitis C genotype 1 undergoing treatment with pegylated-interferon alpha 2a plus ribavirin.
Perrella A; Sbreglia C; Atripaldi L; Esposito C; D'Antonio A; Perrella O
Scand J Gastroenterol; 2010; 45(2):250-5. PubMed ID: 19968615
[TBL] [Abstract][Full Text] [Related]
4. Quantification of serum hepatitis C virus RNA with daily or standard interferon doses plus ribavirin in nonresponder patients with chronic hepatitis C.
Buti M; Olive G; Stalgis C; Esteban R; Guardi J
Dig Dis Sci; 2000 Apr; 45(4):685-9. PubMed ID: 10759235
[TBL] [Abstract][Full Text] [Related]
5. Reduced in vitro immunoglobulin secretion from peripheral blood mononuclear cells in responders to high-dose interferon-alpha 2b treatment for chronic hepatitis C.
Atsukawa K; Saito H; Ebinuma H; Morizane T; Takahashi M; Ohishi T; Kumagai N; Tsuchimoto K; Ishii H
Hepatogastroenterology; 2000; 47(36):1685-90. PubMed ID: 11149032
[TBL] [Abstract][Full Text] [Related]
6. High-Dose interferon-alpha2b plus ribavirin for retreatment of interferon-nonresponsive patients infected with genotype 1 hepatitis C virus.
Buti M; Morral S; Sanchez F; Martell M; Stalgis C; Esteban R
Dig Dis Sci; 2001 Nov; 46(11):2396-400. PubMed ID: 11713942
[TBL] [Abstract][Full Text] [Related]
7. Lower th-1/th-2 ratio before interferon therapy may favor long-term virological responses in patients with chronic hepatitis C.
Masaki N; Fukushima S; Hayashi S
Dig Dis Sci; 2002 Oct; 47(10):2163-9. PubMed ID: 12395887
[TBL] [Abstract][Full Text] [Related]
8. Viral and host factors in determining response of relapsers with chronic hepatitis C to retreatment with interferon.
Almasio PL; Di Marco V; Bonura C; Fuschi P; Camma C; Lo Iacono O; Artini M; Natoli C; Di Stefano R; Levrero M; Craxi A
Dig Dis Sci; 1999 May; 44(5):1013-9. PubMed ID: 10235612
[TBL] [Abstract][Full Text] [Related]
9. Interferon-alpha-induced TRAIL on natural killer cells is associated with control of hepatitis C virus infection.
Stegmann KA; Björkström NK; Veber H; Ciesek S; Riese P; Wiegand J; Hadem J; Suneetha PV; Jaroszewicz J; Wang C; Schlaphoff V; Fytili P; Cornberg M; Manns MP; Geffers R; Pietschmann T; Guzmán CA; Ljunggren HG; Wedemeyer H
Gastroenterology; 2010 May; 138(5):1885-97. PubMed ID: 20334827
[TBL] [Abstract][Full Text] [Related]
10. Increased soluble IL-2 receptor levels during interferon and ribavirin treatment are associated with a good response in genotype 2a/2b patients with chronic hepatitis C.
Abe S; Narita R; Matsuhashi T; Oto T; Tabaru A; Otsuki M
Eur J Gastroenterol Hepatol; 2008 May; 20(5):373-8. PubMed ID: 18403937
[TBL] [Abstract][Full Text] [Related]
11. Quantitation of hepatitis C virus RNA in plasma and peripheral blood mononuclear cells of patients with chronic hepatitis treated with interferon-alpha.
Trimoulet P; Bernard PH; de Ledinghen V; Oui B; Chene G; Saint-Marc Girardin MF; Dantin S; Couzigou P; Fleury H
Dig Dis Sci; 2000 Jan; 45(1):175-81. PubMed ID: 10695632
[TBL] [Abstract][Full Text] [Related]
12. Association of Interferon Alpha Receptor 1 with sustained virological response in hepatitis C and B co-infected patients.
Asim M; Rashid A; Majeed A; Wahid M; Razak S; Jamil A
J Pak Med Assoc; 2017 Jul; 67(7):980-985. PubMed ID: 28770872
[TBL] [Abstract][Full Text] [Related]
13. Interferon-alpha receptor 1 mRNA expression in peripheral blood mononuclear cells is associated with response to interferon-alpha therapy of patients with chronic hepatitis C.
Massirer KB; Hirata MH; Silva AE; Ferraz ML; Nguyen NY; Hirata RD
Braz J Med Biol Res; 2004 May; 37(5):643-7. PubMed ID: 15107924
[TBL] [Abstract][Full Text] [Related]
14. [Effect of ribavirin on dynamics of hepatitis C viremia in interferon alpha-treated patiens with response or no response].
Berg T; Kaul T; Naumann U; Wiedenmann B; Hopf U
Z Gastroenterol; 2000 Nov; 38(11):881-6. PubMed ID: 11132533
[TBL] [Abstract][Full Text] [Related]
15. Virological and biochemical long-term follow-up of patients with chronic hepatitis C treated with interferon.
Castillo I; Bartolomé J; Navas S; Gonzalez S; Herrero M; Carreño V
Hepatology; 1994 Jun; 19(6):1342-6. PubMed ID: 8188165
[TBL] [Abstract][Full Text] [Related]
16. Better efficacy of a 12-month interferon alfa-2b retreatment in patients with chronic hepatitis C relapsing after a 6-month treatment: a multicenter, controlled, randomized trial. Le Groupe D'étude et De Traitement du Virus De L'hépatite C (Get.Vhc).
Payen JL; Izopet J; Galindo-Migeot V; Lauwers-Cances V; Zarski JP; Seigneurin JM; Dussaix E; Voigt JJ; Selves J; Barange K; Puel J; Pascal JP
Hepatology; 1998 Dec; 28(6):1680-6. PubMed ID: 9828235
[TBL] [Abstract][Full Text] [Related]
17. A potent antiviral effect on hepatitis C viral dynamics in serum and peripheral blood mononuclear cells during combination therapy with high-dose daily interferon alfa plus ribavirin and intravenous twice-daily treatment with interferon beta.
Asahina Y; Izumi N; Uchihara M; Noguchi O; Tsuchiya K; Hamano K; Kanazawa N; Itakura J; Miyake S; Sakai T
Hepatology; 2001 Aug; 34(2):377-84. PubMed ID: 11481623
[TBL] [Abstract][Full Text] [Related]
18. Interferon-alpha-2b and ribavirin for retreatment of chronic hepatitis C.
Dettmer RM; Reinus JF; Clain DJ; Aytaman A; Levendoglu H; Bloom AA; Isaacson MP; Spinnell M; Meyer D; Sarabanchong V; Zhang Y; Garcia-Carrasquillo RJ; Markowitz DD; Magun AM; Worman HJ
Hepatogastroenterology; 2002; 49(45):758-63. PubMed ID: 12063985
[TBL] [Abstract][Full Text] [Related]
19. Interferon (IFN)-alpha activation of human blood mononuclear cells in vitro and in vivo for nitric oxide synthase (NOS) type 2 mRNA and protein expression: possible relationship of induced NOS2 to the anti-hepatitis C effects of IFN-alpha in vivo.
Sharara AI; Perkins DJ; Misukonis MA; Chan SU; Dominitz JA; Weinberg JB
J Exp Med; 1997 Nov; 186(9):1495-502. PubMed ID: 9348307
[TBL] [Abstract][Full Text] [Related]
20. Monocyte-derived dendritic cells in children with chronic hepatitis C: correlation with interferon and ribavirin therapy.
Khedr MA; E Behairy B; Hussein ME; Marei AM; Nage SA; Zakaria HM
Eur J Gastroenterol Hepatol; 2015 Oct; 27(10):1170-4. PubMed ID: 26148246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
